Intraoperative radiation therapy (IORT) delivers the full course of radiation therapy during the initial surgical excision.
In the early 2000s, IORT was a promising method of breast cancer treatment de-escalation, offering many advantages.
This technique should have succeeded in the USA, but several factors hindered its widespread adoption.
We report the results of our 15-year IORT registry trial and our reasons for halting the trial.
